gentamicin has been researched along with Chronic Kidney Failure in 135 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We advocate initial treatment of PD peritonitis with non-vancomycin-based therapy given similar efficacy and the potential for reduction of resistant organisms." | 9.11 | Efficacy of a non-vancomycin-based peritoneal dialysis peritonitis protocol. ( Gock, H; Langham, R; Mullins, K; Murphy, B; Snider, J; Toussaint, N, 2005) |
| "Bacterial peritonitis is a well-recognized complication of chronic ambulatory peritoneal dialysis (CAPD) in patients with end-stage renal failure." | 5.33 | Ciprofloxacin treatment of bacterial peritonitis associated with chronic ambulatory peritoneal dialysis caused by Neisseria cinerea. ( Anijeet, H; Corkill, JE; Parry, CM; Saxena, R; Taegtmeyer, M, 2006) |
| " We studied the possible protective effect of the antioxidant N-acetylcysteine (NAC) in gentamicin-induced hearing loss in hemodialysis patients." | 5.12 | Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. ( Abramsohn, R; Averbukh, Z; Efrati, S; Eviatar, E; Feldman, L; Gersch, E; Weissgarten, J; Yarovoy, I, 2007) |
| "The practice of locking newly inserted tunneled central venous catheters with gentamicin and heparin is an effective strategy to reduce line sepsis rates, and is associated with beneficial effects on epoetin requirements." | 5.11 | Locking of tunneled hemodialysis catheters with gentamicin and heparin. ( Fluck, RJ; Hulme, LJ; McIntyre, CW; Taal, M, 2004) |
| "We advocate initial treatment of PD peritonitis with non-vancomycin-based therapy given similar efficacy and the potential for reduction of resistant organisms." | 5.11 | Efficacy of a non-vancomycin-based peritoneal dialysis peritonitis protocol. ( Gock, H; Langham, R; Mullins, K; Murphy, B; Snider, J; Toussaint, N, 2005) |
| "The aim of this study was to describe the safety profile and pharmacokinetic/pharmacodynamic parameters in end-stage renal disease patients who received gentamicin as empirical treatment in catheter-related bacteremia when they showed infection signs, regardless of the timing of the next HD." | 3.91 | Gentamicin as Empirical Treatment in Hemodialysis Patients: Safety, Pharmacokinetics, and Pharmacodynamics. ( Camacho-Martínez, P; Gil-Navarro, MV; Gil-Sacaluga, L; Guisado-Gil, AB; Herrera-Hidalgo, L; Lepe-Jiménez, JA; Molina, J; Santos-Rubio, MD, 2019) |
| " In this nested case-control study, independent AKI risk factors were vancomycin coadministration, high AG trough levels and heart failure." | 3.81 | Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study. ( Ammann, H; Bernier-Jean, A; Bouchard, J; Brunette, V; Lavergne, V; Paquette, F; Pichette, V; Troyanov, S, 2015) |
| "A 65-year-old man with end-stage renal disease on continuous ambulatory peritoneal dialysis accidentally received an acute massive overdose of gentamicin as a treatment of peritonitis." | 3.69 | Acute massive gentamicin intoxication in a patient with end-stage renal disease. ( James, SH; Lien, YH; Lu, CM, 1996) |
| "A prospective study was undertaken of 10 chronic renal failure patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) complicated by repeated bouts of peritonitis treated with gentamicin." | 3.68 | Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis. ( Aziz, NS; Gendeh, BS; Gibb, AG; Kong, N; Said, H; Zahir, ZM, 1993) |
| "Interstitial nephritis with acute renal failure was observed in 5 cases out of 6 treated by the association of methicillin and gentamycin, wheras no case, was observed when each of these antibodies was used separately." | 3.65 | [The nephrotoxicity of the methicillin-gentamycin combination. Apropos of 5 cases]. ( Becq-Giraudon, B; Pourrat, O; Sudre, Y; Yver, L, 1976) |
| " Predialysis every-other-day dosing may be recommended during SDHD." | 2.77 | Gentamicin pharmacokinetics and pharmacodynamics during short-daily hemodialysis. ( Chambers, M; Decker, BS; Kraus, MA; Moe, SM; Mohamed, AN; Sowinski, KM, 2012) |
| " But the safety of long-term use of antimicrobial lock still needs to be defined." | 2.74 | Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method. ( Chen, J; Lv, R; Tan, H; Yuan, J; Zhang, P, 2009) |
| "Thrombosis was defined as the inability to use catheter at a blood flow of 200 ml/min despite intraluminal thrombolysis." | 2.72 | Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. ( Abu-Oun, BA; Al-Ghamdi, AA; Al-Hafiz, A; Hussain, SM; Naguib, M; Panhotra, BR; Saxena, AK; Sundaram, DS; Venkateshappa, CK, 2006) |
| "The aim of this study was to evaluate dosing schedules of gentamicin in patients with end-stage renal disease and receiving hemodialysis." | 2.72 | Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis. ( Dang, L; Duffull, S; Johnson, DW; Teigen, MM, 2006) |
| " Pharmacokinetic parameters were calculated assuming a one-compartment model." | 2.71 | Gentamicin pharmacokinetics during slow daily home hemodialysis. ( Bailie, GR; Bender, WL; Manley, HJ; McClaran, ML, 2003) |
| "Gentamicin use was a significant predictor of lower peritonitis rates (relative risk, 0." | 2.71 | Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. ( Bender, F; Bernardini, J; Florio, T; Fried, L; Palmmontalbano, L; Piraino, B; Sloand, J, 2005) |
| " The results of this study suggest that no additional dosage adjustment of isepamicin during concomitant therapy with piperacillin in hemodialysis patients is necessary." | 2.67 | Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease. ( Affrime, MB; Awni, WM; Halstenson, CE; Heim-Duthoy, KL; Herman, CS; Keane, WF; Kelloway, JH; Teal, MA; Wong, MO, 1992) |
| "The subsequent recurrence rate of peritonitis following CAPD catheter replacement (5%) was significantly less than after urokinase (41%) (p less than 0." | 2.66 | Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis. ( Boletis, I; Brown, CB; Cohen, GL; el Nahas, AM; Johnson, BF; Moorhead, PJ; Raftery, AT; Williams, AJ, 1989) |
| "Gentamicin was inactivated to a greater extent by carbenicillin than by piperacillin (P less than 0." | 2.65 | Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease. ( Atkin-Thor, E; Matsen, JM; Russo, ME; Saxon, BJ; Thompson, MI, 1982) |
| "Drug-induced myoclonus is a diagnosis of exclusion." | 2.48 | Gentamicin-induced myoclonus: a case report and literature review of antibiotics-induced myoclonus. ( Panichpisal, K; Sarva, H, 2012) |
| " The purpose of this paper is to review the concepts pertinent to drug removal by hemodialysis and discuss the issues related to these new dialysis techniques and how they may have a impact on drug removal and the design of dosing regimens." | 2.44 | Drug dosing considerations in alternative hemodialysis. ( Decker, BS; Mueller, BA; Sowinski, KM, 2007) |
| "Pseudomonas peritonitis is a serious complication of peritoneal dialysis (PD)." | 1.48 | Peritoneal dialysis-related peritonitis caused by Pseudomonas species: Insight from a post-millennial case series. ( Chow, KM; Kwan, BC; Leung, CB; Li, PK; Lu, W; Pang, WF; Szeto, CC, 2018) |
| "Our study supports the original FDA label with regard to the dosing regimen of gentamicin in ESRD patients, which offers adequate clinical benefit as well as an acceptable safety profile." | 1.43 | Gentamicin dosing strategy in patients with end-stage renal disease receiving haemodialysis: evaluation using a semi-mechanistic pharmacokinetic/pharmacodynamic model. ( Derendorf, H; He, Y; Liu, Y; Sy, SK; Xia, H; Zhuang, L, 2016) |
| "Diabetic nephropathy is one of the leading causes of end-stage renal disease (ESRD)." | 1.35 | Pharmacokinetics of gentamicin in hemodialysis patients: a comparative study between diabetic and non-diabetic patients. ( Al-Homrany, MA; El Sherif, AK; Irshaid, YM; Omar, HA, 2009) |
| "We report a pneumonia in a patient with chronic renal failure, who had chronic rejection of transplanted kidney." | 1.33 | A case of pneumonia caused by Ewingella americana in a patient with chronic renal failure. ( Ha, JS; Jeon, DS; Kim, HC; Kim, JR; Ryoo, NH, 2005) |
| "Peritonitis is a major complication of peritoneal dialysis (PD)." | 1.33 | Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis. ( Jeyaratnam, D; Keenan, N; Sheerin, NS, 2005) |
| " Analysis included pharmacokinetic parameters in stage 5 CKD, ARF, impact of the dialysis prescription, and treatment results of individualized dosing regimens lasting more than 4 days." | 1.33 | Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing. ( Dager, WE; King, JH, 2006) |
| "The aim of this study was to ascertain the most suitable dosing schedule for gentamicin in patients receiving hemodialysis." | 1.33 | Development of a semimechanistic model to describe the pharmacokinetics of gentamicin in patients receiving hemodialysis. ( Dang, L; Duffull, S, 2006) |
| "Bacterial peritonitis is a well-recognized complication of chronic ambulatory peritoneal dialysis (CAPD) in patients with end-stage renal failure." | 1.33 | Ciprofloxacin treatment of bacterial peritonitis associated with chronic ambulatory peritoneal dialysis caused by Neisseria cinerea. ( Anijeet, H; Corkill, JE; Parry, CM; Saxena, R; Taegtmeyer, M, 2006) |
| " All of the pharmacokinetic parameters of interest were determined using Bayesian pharmacokinetic procedures and only two plasma gentamicin concentrations." | 1.32 | Bayesian pharmacokinetics of gentamicin in a haemodialysis population. ( Ariano, RE; Vercaigne, LM; Zacharias, JM, 2004) |
| "multocida peritonitis have been reported in adults." | 1.30 | Pasteurella multocida peritonitis in patients undergoing peritoneal dialysis. ( Loghman-Adham, M, 1997) |
| "4 mg, whereas the intradialytic gentamicin half-life was 2." | 1.30 | Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulfone membranes. ( Amin, NB; Anandan, JV; Dunfee, TP; Padhi, ID; Patel, RV; Touchette, MA, 1999) |
| " These data indicate that dosage adjustments are necessary in subjects with decreased renal function." | 1.28 | Isepamicin disposition in subjects with various degrees of renal function. ( Affrime, MB; Awni, WM; Halstenson, CE; Kelloway, JS; Lin, CC; Shapiro, BE; Teal, MA, 1991) |
| "Gentamicin is well known to be a cause of vestibular toxicity." | 1.28 | Vestibular toxicity due to gentamicin in peritoneal dialysis patients. ( Bernardini, J; Chong, TK; Piraino, B, 1991) |
| "Eighteen patients with chronic renal failure of diverse causes were followed from initiation of the CAPD program since January 1981 until June 1988." | 1.28 | [Peritonitis in continuous ambulatory peritoneal dialysis. Microbiological and clinical evaluation]. ( Abalo, AB; Prado, A; Predari, SC; Ribas, CM; Santoianni, JE; Zucchini, A, 1990) |
| "A third patient with chronic renal failure acquired A hydrophila pneumonia at home and quickly died from the infection." | 1.26 | Pneumonia and bacteremia due to Aeromonas hydrophila. ( Cook, FV; Reines, HD, 1981) |
| " This relationship provides a basis for formulating gentamicin dosage in pediatric patients with renal failure." | 1.26 | Determining gentamicin dosage in infants and children with renal failure. ( McCracken, GH; Nelson, JD; Sirinavin, S, 1980) |
| " Dosage of gentamicin sulfate was 1." | 1.26 | Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapy. ( Dominguez-Moreno, M; Gailiunas, P; Gottlieb, MN; Lazarus, M; Lowrie, EG; Merrill, JP, 1978) |
| " The kinetic model developed can be used to determine gentamicin dosing for hemodialysis patients and to determine an average elimination rate constant for a given dialysis apparatus." | 1.26 | Prediction of serum gentamicin concentrations in patients undergoing hemodialysis. ( Bloom, P; Goetz, DR; Hoag, S; Pancorbo, S, 1980) |
| "Fifty-seven cancer patients, who had had an 8--15% loss of body weight in the previous 6 months, were studied to establish the reliabity in wasted individuals of presently available nomograms correlating serum creatinine with creatinine clearance." | 1.26 | Nephrotoxic antibiotics in patients with renal failures: guidelines for debilitated patients. ( Carlon, GC; Colaco, FM; Goldiner, PL; Howland, WS; Scheiner, E, 1979) |
| " As a first step in the study of the effects of renal insufficiency and the anephric state on the pharmacokinetic parameters of gentamicin, serum and urine levels of this drug were studied after a single intravenous bolus dose during hemodialysis in patients suffering from chronic renal failure." | 1.26 | Gentamicin pharmacokinetics during hemodialysis in patients suffering from chronic renal failure. ( Daigneault, R; Lapierre, L; Létourneau-Saheb, L; Prud'Homme, M; Serois, G; St-Louis, G, 1977) |
| "Reversible acute renal failure was observed in 13 patients after combined antibiotic therapy using gentamicin." | 1.26 | [Nephrotoxicity of gentamicin. Conditions for the use of this antibiotic in the elderly and in the patient with renal insufficiency]. ( Ganeval, D; Jungers, P; Kleinknecht, D, 1977) |
| " The results indicate that gentamicin requirements are underestimated by methods currently employed to calculate dosage for patients with renal failure who receive carbenicillin concurrently." | 1.26 | Inactivation of gentamicin by penicillins in patients with renal failure. ( Bullock, WE; Ervin, FR; Nuttall, CE, 1976) |
| "Carbenicillin appears to produce clinically important inactivation of aminoglycoside antibiotics in patients with severe renal failure." | 1.26 | Carbenicillin inactivation of aminoglycosides in patients with severe renal failure. ( Keane, W; Shapiro, F; Weibert, R, 1976) |
| "A pharmacokinetic study of netilmicin was conducted in 12 healthy subjects and 24 subjects with chronic renal failure." | 1.26 | Pharmacokinetics of netilmicin in the presence of normal or impaired renal function. ( Fillastre, JP; Humbert, G; Leroy, A; Oksenhendler, G, 1978) |
| "Gentamicin treatment in patients with grossly decreased renal function should thus be performed under control of serum levels." | 1.26 | [Is endogenous creatinine clearance a sound basis for estimation of elimination half life of gentamicin?]. ( Graninger, W; Hitzenberger, G; Jaschek, I; Rameis, H, 1980) |
| "Netilmicin serum levels were within expected values." | 1.26 | Prophylactic netilmicin in surgery. ( Abbas, AM; Jones, RB; Rigby, CC; Zaman, MM, 1982) |
| " Recent studies have emphasized the dubious accuracy of commonly used formulas, and computer programs that provide pharmacokinetic data for individual patients from multiple blood samples have helped to adjust dosages but are expensive." | 1.26 | Gentamicin: use of a programmable calculator to determine dosages from pharmacokinetic data for individual patients. ( Courchesne, Y; de Repentigny, L; Dumont, L; Larochelle, P; Le Lorier, J; Morisset, R, 1981) |
| " Subsequent clearance of gentamicin from the serum occurred slowly with an elimination half-life of 36 h." | 1.26 | Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis. ( Comty, C; Pancorbo, S, 1981) |
| "Cephaloridine has some renal toxic effects in high concentration; in the renal failure it is advisable to calculate the exact dose of the antibiotic by the use of nomograms when the creatinine clearance is known." | 1.25 | [Antibiotic therapy and renal insufficiency. Pharmacokinetics of pivampicillin, cephaloridin and streptomycin in chronic uremic patients undergoing conservative or hemodialytic treatment]. ( Bertoli, M; Campanacci, L; Cancarini, GC; Huber, W; Toigo, G, 1975) |
| " time profiles of various dosage regimens recommended for renal impairment were reassessed by applying pharmacokinetic techniques to the patient data in the clinical literature." | 1.25 | Practical pharmacokinetic techniques for drug consultation and evaluation. IV: Gentamicin blood level versus time profiles of various dosage regimens recommended for renal impairment. ( Schumacher, GE, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 80 (59.26) | 18.7374 |
| 1990's | 15 (11.11) | 18.2507 |
| 2000's | 27 (20.00) | 29.6817 |
| 2010's | 13 (9.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, W | 1 |
| Kwan, BC | 1 |
| Chow, KM | 2 |
| Pang, WF | 1 |
| Leung, CB | 2 |
| Li, PK | 2 |
| Szeto, CC | 2 |
| Guisado-Gil, AB | 1 |
| Herrera-Hidalgo, L | 1 |
| Santos-Rubio, MD | 1 |
| Gil-Sacaluga, L | 1 |
| Molina, J | 1 |
| Lepe-Jiménez, JA | 1 |
| Camacho-Martínez, P | 1 |
| Gil-Navarro, MV | 1 |
| Kwan, C | 1 |
| Chen, O | 1 |
| Radionova, S | 1 |
| Sadiq, A | 1 |
| Moskovits, M | 1 |
| Paquette, F | 1 |
| Bernier-Jean, A | 1 |
| Brunette, V | 1 |
| Ammann, H | 1 |
| Lavergne, V | 1 |
| Pichette, V | 1 |
| Troyanov, S | 1 |
| Bouchard, J | 1 |
| Zhuang, L | 1 |
| He, Y | 1 |
| Xia, H | 1 |
| Liu, Y | 1 |
| Sy, SK | 1 |
| Derendorf, H | 1 |
| Al-Homrany, MA | 1 |
| Irshaid, YM | 1 |
| El Sherif, AK | 1 |
| Omar, HA | 1 |
| Zhang, P | 1 |
| Yuan, J | 1 |
| Tan, H | 1 |
| Lv, R | 1 |
| Chen, J | 1 |
| Polaschegg, HD | 1 |
| Deschênes, G | 1 |
| Allon, M | 1 |
| Fitzgibbons, LN | 1 |
| Puls, DL | 1 |
| Mackay, K | 1 |
| Forrest, GN | 1 |
| Filiopoulos, V | 1 |
| Hadjiyannakos, D | 1 |
| Koutis, I | 1 |
| Trompouki, S | 1 |
| Micha, T | 1 |
| Lazarou, D | 1 |
| Vlassopoulos, D | 1 |
| Castillo, RF | 1 |
| Cañadas-De la Fuente, GA | 1 |
| Husein-Elahmed, H | 1 |
| Cantero-Hinojosa, J | 1 |
| Pinner, NA | 1 |
| Canada, RB | 1 |
| Broyles, JE | 1 |
| Hudson, JQ | 1 |
| Decker, BS | 2 |
| Mohamed, AN | 1 |
| Chambers, M | 1 |
| Kraus, MA | 1 |
| Moe, SM | 1 |
| Sowinski, KM | 2 |
| Sarva, H | 1 |
| Panichpisal, K | 1 |
| Manley, HJ | 1 |
| Bailie, GR | 1 |
| McClaran, ML | 1 |
| Bender, WL | 1 |
| Wang, IK | 1 |
| Chen, YM | 1 |
| Chen, YC | 1 |
| Fang, JT | 1 |
| Hang, CC | 1 |
| Karataş, Y | 1 |
| Seçilmiş, MA | 1 |
| Karayaylali, I | 1 |
| Doran, F | 1 |
| Büyükafşar, K | 1 |
| Singirik, E | 1 |
| Sagliker, Y | 1 |
| Dikmen, A | 1 |
| Vercaigne, LM | 1 |
| Ariano, RE | 1 |
| Zacharias, JM | 1 |
| McIntyre, CW | 2 |
| Hulme, LJ | 2 |
| Taal, M | 2 |
| Fluck, RJ | 2 |
| Wang, Y | 1 |
| Iwatani, H | 1 |
| Ito, T | 1 |
| Horimoto, N | 1 |
| Yamato, M | 1 |
| Matsui, I | 1 |
| Imai, E | 1 |
| Hori, M | 1 |
| Lambie, SH | 1 |
| Bernardini, J | 2 |
| Bender, F | 1 |
| Florio, T | 1 |
| Sloand, J | 1 |
| Palmmontalbano, L | 1 |
| Fried, L | 1 |
| Piraino, B | 2 |
| Ryoo, NH | 1 |
| Ha, JS | 1 |
| Jeon, DS | 1 |
| Kim, JR | 1 |
| Kim, HC | 1 |
| Keenan, N | 1 |
| Jeyaratnam, D | 1 |
| Sheerin, NS | 1 |
| Toussaint, N | 1 |
| Mullins, K | 1 |
| Snider, J | 1 |
| Murphy, B | 1 |
| Langham, R | 1 |
| Gock, H | 1 |
| Dager, WE | 1 |
| King, JH | 1 |
| Dang, L | 2 |
| Duffull, S | 2 |
| Taegtmeyer, M | 1 |
| Saxena, R | 1 |
| Corkill, JE | 1 |
| Anijeet, H | 1 |
| Parry, CM | 1 |
| Saxena, AK | 1 |
| Panhotra, BR | 1 |
| Sundaram, DS | 1 |
| Al-Hafiz, A | 1 |
| Naguib, M | 1 |
| Venkateshappa, CK | 1 |
| Abu-Oun, BA | 1 |
| Hussain, SM | 1 |
| Al-Ghamdi, AA | 1 |
| Teigen, MM | 1 |
| Johnson, DW | 1 |
| Feldman, L | 1 |
| Efrati, S | 1 |
| Eviatar, E | 1 |
| Abramsohn, R | 1 |
| Yarovoy, I | 1 |
| Gersch, E | 1 |
| Averbukh, Z | 1 |
| Weissgarten, J | 1 |
| Al-Hwiesh, AK | 1 |
| Abdul-Rahman, IS | 1 |
| Molostvov, G | 1 |
| James, S | 1 |
| Fletcher, S | 1 |
| Bennett, J | 1 |
| Lehnert, H | 1 |
| Bland, R | 1 |
| Zehnder, D | 1 |
| Mueller, BA | 1 |
| Tepel, M | 1 |
| Gabriel, R | 1 |
| Valsamis, J | 1 |
| Brauman, H | 1 |
| Yourassowsky, E | 3 |
| Mejia, G | 1 |
| Leiderman, E | 1 |
| Builes, M | 1 |
| Henao, J | 1 |
| Arbelaez, M | 1 |
| Arango, JL | 1 |
| Borrero, J | 1 |
| Thompson, MI | 1 |
| Russo, ME | 1 |
| Saxon, BJ | 1 |
| Atkin-Thor, E | 1 |
| Matsen, JM | 1 |
| Takasugi, M | 1 |
| Hasegawa, O | 1 |
| Soejima, M | 1 |
| Yu, K | 1 |
| Muta, T | 1 |
| Matsuura, K | 1 |
| Nakashima, Y | 1 |
| Kuroiwa, A | 1 |
| Kunifuji, Y | 1 |
| Nakamura, T | 1 |
| Schulz, E | 1 |
| Busse, FW | 1 |
| Strasburger, C | 1 |
| Herhahn, J | 1 |
| Wood, WG | 1 |
| Sack, K | 1 |
| Matzke, GR | 1 |
| Halstenson, CE | 3 |
| Keane, WF | 2 |
| Vogel, F | 1 |
| Exner, M | 1 |
| von Lilienfeld-Toal, H | 1 |
| Cattelaens, N | 1 |
| Eichelbaum, M | 1 |
| Berry, PL | 1 |
| Kearns, GL | 1 |
| Brown, RD | 1 |
| Ritschel, WA | 1 |
| Thompson, GA | 1 |
| McEnery, PT | 1 |
| Ramsden, RT | 1 |
| Ackrill, P | 1 |
| Blair, DC | 1 |
| Duggan, DO | 1 |
| Schroeder, ET | 1 |
| Abbas, AM | 1 |
| Jones, RB | 1 |
| Rigby, CC | 1 |
| Zaman, MM | 1 |
| Riviere, JE | 1 |
| de Repentigny, L | 1 |
| Dumont, L | 1 |
| Le Lorier, J | 1 |
| Morisset, R | 1 |
| Larochelle, P | 1 |
| Courchesne, Y | 1 |
| Pancorbo, S | 2 |
| Comty, C | 1 |
| Reines, HD | 1 |
| Cook, FV | 1 |
| Crass, RE | 1 |
| Sirinavin, S | 1 |
| McCracken, GH | 1 |
| Nelson, JD | 1 |
| Goetz, DR | 1 |
| Hoag, S | 1 |
| Bloom, P | 1 |
| Rameis, H | 1 |
| Hitzenberger, G | 1 |
| Jaschek, I | 1 |
| Graninger, W | 1 |
| Zurovsky, Y | 1 |
| Haber, C | 1 |
| Kuranari, M | 1 |
| Nawata, T | 1 |
| Sato, Y | 1 |
| Sakata, T | 1 |
| Kodama, Y | 1 |
| Takeyama, M | 1 |
| Gendeh, BS | 1 |
| Said, H | 1 |
| Gibb, AG | 1 |
| Aziz, NS | 1 |
| Kong, N | 1 |
| Zahir, ZM | 1 |
| Vijayvargiya, R | 1 |
| Veis, JH | 1 |
| Lu, CM | 1 |
| James, SH | 1 |
| Lien, YH | 1 |
| Loghman-Adham, M | 1 |
| Green, KM | 1 |
| Lappin, DW | 1 |
| Curley, JW | 1 |
| de Carpentier, JP | 1 |
| Amin, NB | 1 |
| Padhi, ID | 1 |
| Touchette, MA | 1 |
| Patel, RV | 1 |
| Dunfee, TP | 1 |
| Anandan, JV | 1 |
| Easom, A | 1 |
| Fattal, O | 1 |
| Deville, JG | 1 |
| Wong, TY | 1 |
| Wu, AK | 1 |
| Wang, AY | 1 |
| Lui, SF | 1 |
| Cohen, HJ | 1 |
| Rundles, RW | 1 |
| Yver, L | 1 |
| Becq-Giraudon, B | 1 |
| Pourrat, O | 1 |
| Sudre, Y | 1 |
| Leroy, A | 2 |
| Oksenhendler, G | 2 |
| Fillastre, JP | 2 |
| Humbert, G | 2 |
| Bloomfield, SE | 1 |
| David, DS | 1 |
| Cheigh, JS | 1 |
| Kim, Y | 1 |
| White, RP | 1 |
| Stenzel, KH | 1 |
| Rubin, AL | 1 |
| Gailiunas, P | 1 |
| Dominguez-Moreno, M | 1 |
| Lazarus, M | 1 |
| Lowrie, EG | 1 |
| Gottlieb, MN | 1 |
| Merrill, JP | 1 |
| Wright, JP | 1 |
| Potgieter, PD | 1 |
| Forder, AA | 1 |
| Botha, P | 1 |
| Brinkworth, G | 1 |
| Elisha, G | 1 |
| Ferguson, AD | 1 |
| Kraft, D | 1 |
| Lode, H | 1 |
| Lindholm, T | 1 |
| Vozeh, S | 1 |
| Spring, P | 2 |
| Wenk, M | 1 |
| Follath, F | 1 |
| Orłowski, T | 1 |
| Wierzba, K | 1 |
| Lazowski, J | 1 |
| Lypka, A | 1 |
| Rumpf, KW | 1 |
| Rieger, J | 1 |
| Doht, B | 1 |
| Ansorg, R | 1 |
| Scheler, F | 1 |
| Carlon, GC | 1 |
| Scheiner, E | 1 |
| Colaco, FM | 1 |
| Howland, WS | 1 |
| Goldiner, PL | 1 |
| Fossati, C | 1 |
| Kröger, E | 1 |
| Rohmann, H | 1 |
| Osten, B | 1 |
| Falkenhagen, U | 1 |
| Létourneau-Saheb, L | 1 |
| Lapierre, L | 1 |
| Daigneault, R | 1 |
| Prud'Homme, M | 1 |
| St-Louis, G | 1 |
| Serois, G | 1 |
| Jungers, P | 1 |
| Ganeval, D | 1 |
| Kleinknecht, D | 1 |
| Ervin, FR | 1 |
| Bullock, WE | 1 |
| Nuttall, CE | 1 |
| Weibert, R | 1 |
| Keane, W | 1 |
| Shapiro, F | 1 |
| Mazzei, T | 1 |
| Paradiso, M | 1 |
| Nicoletti, I | 1 |
| Periti, P | 1 |
| Königshausen, T | 1 |
| Rosin, H | 1 |
| Hagedorn, HJ | 1 |
| Küppers, H | 1 |
| Grabensee, B | 1 |
| Schumacher, GE | 1 |
| Campanacci, L | 1 |
| Huber, W | 1 |
| Bertoli, M | 1 |
| Cancarini, GC | 1 |
| Toigo, G | 1 |
| Wong, MO | 1 |
| Herman, CS | 1 |
| Heim-Duthoy, KL | 1 |
| Teal, MA | 2 |
| Affrime, MB | 2 |
| Kelloway, JH | 1 |
| Awni, WM | 2 |
| Lye, WC | 1 |
| Lee, EJ | 1 |
| Tan, CC | 1 |
| Ishigami, M | 1 |
| Eguchi, M | 1 |
| Yabuki, S | 1 |
| Kelloway, JS | 1 |
| Lin, CC | 1 |
| Shapiro, BE | 1 |
| Chong, TK | 1 |
| Thomson, AH | 1 |
| Grant, AC | 1 |
| Rodger, RS | 1 |
| Hughes, RL | 1 |
| Predari, SC | 1 |
| Abalo, AB | 1 |
| Santoianni, JE | 1 |
| Prado, A | 1 |
| Ribas, CM | 1 |
| Zucchini, A | 1 |
| Williams, AJ | 1 |
| Boletis, I | 1 |
| Johnson, BF | 1 |
| Raftery, AT | 1 |
| Cohen, GL | 1 |
| Moorhead, PJ | 1 |
| el Nahas, AM | 1 |
| Brown, CB | 1 |
| Sedman, AJ | 1 |
| Molitoris, BA | 1 |
| Nakata, LM | 1 |
| Gal, J | 1 |
| Houghton, DC | 1 |
| English, J | 1 |
| Bennett, WM | 1 |
| Verpooten, GA | 1 |
| Giuliano, RA | 1 |
| Pattyn, VM | 1 |
| Scharpé, SL | 1 |
| De Broe, ME | 3 |
| Catolico, MM | 1 |
| Campbell, S | 1 |
| Jones, WN | 1 |
| Logan, JL | 1 |
| Bourbouze, R | 1 |
| Gluckman, JC | 1 |
| Frantz, P | 1 |
| Paraire, M | 1 |
| Baumann, FC | 1 |
| Luciani, J | 1 |
| Percheron, F | 1 |
| Legrain, M | 1 |
| del Río Vázquez, A | 1 |
| Lurie, A | 1 |
| Ogilvie, M | 1 |
| Gold, CH | 1 |
| Meyer, AM | 1 |
| Goldberg, B | 1 |
| Martin, H | 1 |
| Gadot, P | 1 |
| Gignoux, B | 1 |
| Debain, JJ | 1 |
| Freyss, G | 1 |
| Poulain, H | 1 |
| Möhring, K | 1 |
| Schüler, HW | 1 |
| Stöhrer, M | 1 |
| Christopher, TG | 1 |
| Korn, D | 1 |
| Blair, AD | 1 |
| Forrey, AW | 2 |
| O'Neill, MA | 1 |
| Cutler, RE | 2 |
| Thatcher, GN | 1 |
| Höffler, D | 1 |
| Lagrue, G | 1 |
| Fournier, A | 1 |
| Sugarbaker, PH | 1 |
| Sabath, LD | 2 |
| Morgan, AP | 1 |
| Chan, RA | 1 |
| Benner, EJ | 1 |
| Hoeprich, PD | 1 |
| Aboulker, P | 1 |
| Lassner, J | 1 |
| Bürgi, M | 1 |
| Rosaschino, F | 1 |
| Carnelli, V | 1 |
| Bosco, U | 1 |
| Simon, C | 1 |
| Schmitt, E | 1 |
| Malerczyk, V | 1 |
| Arkenau, C | 1 |
| Fabre, J | 1 |
| de Werra, P | 1 |
| Kaye, D | 1 |
| Levison, ME | 1 |
| Labovitz, ED | 1 |
| Gary, NE | 1 |
| Hyams, PJ | 2 |
| Smithivas, T | 2 |
| Matalon, R | 2 |
| Katz, L | 1 |
| Simberkoff, MS | 2 |
| Rahal, JJ | 2 |
| Dume, T | 1 |
| Wetzels, E | 1 |
| Herms, W | 1 |
| Schröder, E | 1 |
| Wahlig, H | 1 |
| Casey, JI | 1 |
| Ruch, PA | 1 |
| Stumpf, LL | 1 |
| Finland, M | 1 |
| Winters, RE | 1 |
| Litwack, KD | 1 |
| Hewitt, WL | 1 |
| Waldvogel, F | 1 |
| Gyselynck, AM | 1 |
| Fleet, WP | 1 |
| Federspil, P | 1 |
| von Oldershausen, HF | 1 |
| Held, H | 1 |
| Menz, HP | 1 |
| Schmidinger, H | 1 |
| Stephens, SD | 1 |
| Gingell, JC | 1 |
| Chisholm, GD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non[NCT02279121] | 162 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| Intradialytic Drug Removal by Short-daily Hemodialysis[NCT00596167] | 6 participants (Actual) | Interventional | 2007-09-30 | Completed | |||
| Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session[NCT03904836] | Phase 1 | 11 participants (Actual) | Interventional | 2019-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"The intradialytic clearance of levofloxacin, gentamicin and vancomycin will be determined in patients receiving short-daily hemodialysis.~(Of important note, due to technical issues the levofloxacin data was not able to be used for the analysis. Only the gentamicin and vancomycin data was analyzed.)" (NCT00596167)
Timeframe: Serum concentrations for each drug will be determined from blood samples at 0 (pre-infusion), 30, 60 minutes (end of infusion).
| Intervention | ml/min (Median) | |
|---|---|---|
| Intravenous antibiotic (vancomycin) | Intravenous antibiotic (gentamicin) | |
| Intravenous Antibiotic (Vancomycin) | 7.2 | 7.6 |
4 reviews available for gentamicin and Chronic Kidney Failure
| Article | Year |
|---|---|
[Renal toxicity of drugs in the neonate].
Topics: Abnormalities, Drug-Induced; Anti-HIV Agents; Bartter Syndrome; Fanconi Syndrome; Female; Gentamicin | 2010 |
Gentamicin-induced myoclonus: a case report and literature review of antibiotics-induced myoclonus.
Topics: Anti-Bacterial Agents; Cephalosporins; Female; Gentamicins; Humans; Kidney Failure, Chronic; Middle | 2012 |
Drug dosing considerations in alternative hemodialysis.
Topics: Anti-Infective Agents, Urinary; Blood Urea Nitrogen; Dose-Response Relationship, Drug; Drug Administ | 2007 |
[Chemo-antibiotics during the course of kidney insufficiency].
Topics: Ampicillin; Anti-Bacterial Agents; Antitubercular Agents; Carbenicillin; Cephalosporins; Chloramphen | 1975 |
15 trials available for gentamicin and Chronic Kidney Failure
| Article | Year |
|---|---|
Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method.
Topics: Adult; Aged; Catheter-Related Infections; Catheters, Indwelling; Female; Gentamicins; Heparin; Human | 2009 |
Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anticoagulants; Catheter-Related Infections; | 2011 |
Gentamicin pharmacokinetics and pharmacodynamics during short-daily hemodialysis.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Female; Gentamicins; Humans; Infusions, Intraven | 2012 |
Gentamicin pharmacokinetics during slow daily home hemodialysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Female; Gentamicins; Hemodialysis, Home; Humans; Injections, Int | 2003 |
Locking of tunneled hemodialysis catheters with gentamicin and heparin.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Anti-Bacterial Agents; Anticoagulants; Catheterization; Cros | 2004 |
Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Topics: Administration, Topical; Adult; Aged; Analysis of Variance; Catheters, Indwelling; Confidence Interv | 2005 |
Efficacy of a non-vancomycin-based peritoneal dialysis peritonitis protocol.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Drug Resistance, Bacterial; Drug Therapy, Combination | 2005 |
Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; | 2006 |
Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Drug Administra | 2006 |
Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Aged; Aminoglycosides; Anti-Bacterial Agents; Antioxidants; Ba | 2007 |
Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Drug Therapy, C | 2007 |
Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease.
Topics: Biotransformation; Carbenicillin; Drug Interactions; Drug Therapy, Combination; Gentamicins; Half-Li | 1982 |
Gentamicin and penicillin in the treatment of severe respiratory infections.
Topics: Adult; Clinical Trials as Topic; Creatinine; Drug Therapy, Combination; Gentamicins; Humans; Infusio | 1979 |
Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease.
Topics: Adult; Gentamicins; Half-Life; Humans; Kidney Failure, Chronic; Piperacillin | 1992 |
Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis.
Topics: Catheters, Indwelling; Female; Gentamicins; Humans; Infusions, Parenteral; Kidney Failure, Chronic; | 1989 |
116 other studies available for gentamicin and Chronic Kidney Failure
| Article | Year |
|---|---|
Peritoneal dialysis-related peritonitis caused by Pseudomonas species: Insight from a post-millennial case series.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Drug Resistance, Bacterial; Female; Gentamicins; Hu | 2018 |
Gentamicin as Empirical Treatment in Hemodialysis Patients: Safety, Pharmacokinetics, and Pharmacodynamics.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Fema | 2019 |
Echocardiography: a case of coronary sinus endocarditis.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Coronary Sinus; Diagnosis, Differential; Endocarditis; Fe | 2014 |
Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Aminoglycosides; Antineoplastic Agents; Case-Control S | 2015 |
Gentamicin dosing strategy in patients with end-stage renal disease receiving haemodialysis: evaluation using a semi-mechanistic pharmacokinetic/pharmacodynamic model.
Topics: Algorithms; Anti-Bacterial Agents; Bacterial Infections; Gentamicins; Humans; Kidney Failure, Chroni | 2016 |
Pharmacokinetics of gentamicin in hemodialysis patients: a comparative study between diabetic and non-diabetic patients.
Topics: Adult; Anti-Bacterial Agents; Diabetic Nephropathies; Female; Gentamicins; Humans; Kidney Failure, C | 2009 |
Loss of catheter lock fluid is caused by hydraulic effects and not by diffusion.
Topics: Adult; Aged; Catheter-Related Infections; Catheters, Indwelling; Female; Gentamicins; Heparin; Human | 2009 |
Dialysis: Are prophylactic gentamicin catheter locks safe?
Topics: Anti-Bacterial Agents; Catheters, Indwelling; Drug Resistance, Bacterial; Gentamicins; Humans; Kidne | 2011 |
Management of gram-positive coccal bacteremia and hemodialysis.
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Daptomycin; Drug Resistance, Bacterial; En | 2011 |
Pyoderma gangrenosum developing over an arteriovenous fistula scar.
Topics: Abscess; Arteriovenous Shunt, Surgical; Betamethasone Valerate; Drug Therapy, Combination; Gentamici | 2011 |
Evaluation of vancomycin and gentamicin dialysis clearance using in vivo and in vitro systems.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dialysis Solutions; Female; Genta | 2012 |
Successful treatment of renal abscess with percutaneous needle aspiration in a diabetic patient with end stage renal disease undergoing hemodialysis.
Topics: Abscess; Aged; Anti-Bacterial Agents; Biopsy, Fine-Needle; Ceftriaxone; Diabetes Mellitus, Type 2; D | 2003 |
Effect of tempol (4-hydroxy tempo) on gentamicin-induced nephrotoxicity in rats.
Topics: Animals; Anti-Bacterial Agents; Blood Urea Nitrogen; Creatinine; Cyclic N-Oxides; Gentamicins; Kidne | 2004 |
Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
Topics: Adult; Aged; Anti-Bacterial Agents; Bayes Theorem; Gentamicins; Gram-Negative Bacterial Infections; | 2004 |
Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury.
Topics: Animals; Chimerism; Ethanol; Female; Fetus; Gentamicins; Kidney; Kidney Failure, Chronic; Liver; Liv | 2004 |
Prospective study of gentamicin locking of tunnelled dialysis catheters: the effect on infection rates and CRP.
Topics: C-Reactive Protein; Catheters, Indwelling; Gentamicins; Humans; Infection Control; Kidney Failure, C | 2005 |
A case of pneumonia caused by Ewingella americana in a patient with chronic renal failure.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Gentam | 2005 |
Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Antiretroviral Therapy, Highly | 2005 |
Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
Topics: Acute Kidney Injury; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Comorbidity; Fema | 2006 |
Development of a semimechanistic model to describe the pharmacokinetics of gentamicin in patients receiving hemodialysis.
Topics: Anti-Bacterial Agents; Area Under Curve; Female; Gentamicins; Humans; Kidney Failure, Chronic; Male; | 2006 |
Ciprofloxacin treatment of bacterial peritonitis associated with chronic ambulatory peritoneal dialysis caused by Neisseria cinerea.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Gentamicins; Humans; Kidney Failure, Chronic; Male; Nei | 2006 |
Extracellular calcium-sensing receptor is functionally expressed in human artery.
Topics: Arteries; Calcium; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Gentamicins; Humans; | 2007 |
N-Acetylcysteine in the prevention of ototoxicity.
Topics: Acetylcysteine; Administration, Oral; Aminoglycosides; Anti-Bacterial Agents; Antioxidants; Bacterem | 2007 |
Nephrotoxicity of aminoglycosides.
Topics: Gentamicins; Humans; Kidney; Kidney Failure, Chronic | 1982 |
Plasma beta 2 microglobulin as a means of predicting gentamicin serum concentrations.
Topics: Adult; Aged; beta 2-Microglobulin; Beta-Globulins; Body Weight; Child; Creatinine; Gentamicins; Glom | 1980 |
Transmission of toxoplasmosis by renal transplant.
Topics: Adult; Cephalothin; Female; Gentamicins; Graft Rejection; Humans; Kidney Failure, Chronic; Kidney Tr | 1983 |
[Gentamicin pharmacokinetics during hemodialysis].
Topics: Adult; Female; Gentamicins; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Renal Dial | 1984 |
[Serum gentamicin level after intratracheal application in ventilated patients with normal and reduced kidney function].
Topics: Adult; Aged; Female; Gentamicins; Humans; Intubation, Intratracheal; Kidney Failure, Chronic; Male; | 1983 |
Hemodialysis elimination rates and clearance of gentamicin and tobramycin.
Topics: Aged; Female; Gentamicins; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; | 1984 |
Serum gentamicin concentrations during intratracheal administration.
Topics: Acute Kidney Injury; Adult; Female; Gentamicins; Humans; Intubation, Intratracheal; Kidney Failure, | 1984 |
Gentamicin disposition in children with chronic renal failure.
Topics: Adolescent; Child; Creatinine; Gentamicins; Humans; Kidney Failure, Chronic; Kinetics; Time Factors; | 1982 |
Bobbing oscillopsia from gentamicin toxicity.
Topics: Gentamicins; Humans; Kidney Failure, Chronic; Labyrinth Diseases; Renal Dialysis; Vestibule, Labyrin | 1982 |
Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure.
Topics: Amikacin; Carbenicillin; Drug Interactions; Gentamicins; Humans; Kanamycin; Kidney Failure, Chronic; | 1982 |
Prophylactic netilmicin in surgery.
Topics: Adult; Aged; Female; Gentamicins; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Netilm | 1982 |
Dosage of antimicrobial drugs in patients with renal insufficiency.
Topics: Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Gentamicins; Kidney Failure, Chronic | 1981 |
Gentamicin: use of a programmable calculator to determine dosages from pharmacokinetic data for individual patients.
Topics: Bacterial Infections; Computers; Gentamicins; Half-Life; Humans; Kidney Failure, Chronic | 1981 |
Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis.
Topics: Adult; Aged; Ambulatory Care; Gentamicins; Humans; Kidney Failure, Chronic; Kinetics; Middle Aged; P | 1981 |
Pneumonia and bacteremia due to Aeromonas hydrophila.
Topics: Adolescent; Adult; Aeromonas; Female; Gentamicins; Humans; Kidney Failure, Chronic; Lung; Lung Absce | 1981 |
Gentamicin-induced ototoxicity in a carefully monitored renal-failure patient.
Topics: Adult; Drug Interactions; Ear; Gentamicins; Humans; Kidney Failure, Chronic; Male; Monitoring, Physi | 1981 |
Determining gentamicin dosage in infants and children with renal failure.
Topics: Bacterial Infections; Child; Child, Preschool; Creatinine; Gentamicins; Half-Life; Humans; Infant; I | 1980 |
Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
Topics: Adult; Aged; Bacterial Infections; Drug Administration Schedule; Gentamicins; Humans; Kidney Failure | 1980 |
[Is endogenous creatinine clearance a sound basis for estimation of elimination half life of gentamicin?].
Topics: Adult; Aged; Creatinine; Gentamicins; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, | 1980 |
Antioxidants attenuate endotoxin-gentamicin induced acute renal failure in rats.
Topics: Animals; Antioxidants; Dose-Response Relationship, Drug; Endotoxins; Free Radical Scavengers; Gentam | 1995 |
Effect of hemodialysis on serum concentration of isepamicin in a patient with endstage renal failure.
Topics: Aged; Gentamicins; Half-Life; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Renal | 1993 |
Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis.
Topics: Adult; Audiometry, Pure-Tone; Drug Administration Schedule; Electronystagmography; Gentamicins; Huma | 1993 |
Antibiotic-resistant endocarditis in a hemodialysis patient.
Topics: Ampicillin; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug T | 1996 |
Acute massive gentamicin intoxication in a patient with end-stage renal disease.
Topics: Aged; Anti-Bacterial Agents; Drug Overdose; Gentamicins; Hearing Loss, High-Frequency; Hemoperfusion | 1996 |
Pasteurella multocida peritonitis in patients undergoing peritoneal dialysis.
Topics: Anti-Bacterial Agents; Child; Female; Gentamicins; Glomerulosclerosis, Focal Segmental; Humans; Inje | 1997 |
Systemic absorption of gentamicin ear drops.
Topics: Absorption; Administration, Topical; Anti-Bacterial Agents; Gentamicins; Humans; Kidney Failure, Chr | 1997 |
Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulfone membranes.
Topics: Aged; Female; Gentamicins; Half-Life; Humans; Kidney Failure, Chronic; Male; Membranes, Artificial; | 1999 |
Prophylactic antibiotic lock therapy for hemodialysis catheters.
Topics: Anti-Bacterial Agents; Arteriovenous Shunt, Surgical; Cross Infection; Gentamicins; Humans; Infectio | 2000 |
Leclercia adecarboxylata peritonitis in a child receiving chronic peritoneal dialysis.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Child, Preschool; Enterobacteriaceae Infections; E | 2000 |
Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Equipment Contamination; Female; Gentamicins; Hu | 2001 |
Managing the complications of plasma cell myeloma.
Topics: Acute Kidney Injury; Bacterial Infections; Blood Urea Nitrogen; Blood Viscosity; Bone Neoplasms; Cep | 1975 |
[The nephrotoxicity of the methicillin-gentamycin combination. Apropos of 5 cases].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Eosinophilia; Fever; Gentamicins; Hematuria; Hum | 1976 |
[Pharmacokinetics of lividomycin, aminkacin and sisomicin in patients with chronic renal insufficiency].
Topics: Amikacin; Gentamicins; Humans; Kanamycin; Kidney Failure, Chronic; Kinetics; Paromomycin; Sisomicin | 1977 |
Endophthalmitis following staphylococcal sepsis in renal failure patients.
Topics: Adult; Atropine; Chronic Disease; Dexamethasone; Dicloxacillin; Endophthalmitis; Female; Gentamicins | 1978 |
Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapy.
Topics: Adult; Aged; Body Weight; Female; Gentamicins; Humans; Kidney Failure, Chronic; Labyrinth Diseases; | 1978 |
Elimination of ampicillin and gentamicin by hemofiltration.
Topics: Ampicillin; Blood; Filtration; Gentamicins; Half-Life; Humans; Kidney Failure, Chronic; Renal Dialys | 1979 |
[Urinary tract infections. Problems in treating dialysis patients with toxic drugs].
Topics: Anti-Bacterial Agents; Gentamicins; Humans; Kidney Failure, Chronic; Renal Dialysis; Urinary Tract I | 1979 |
Changes in the apparent half life of gentamicin and tobramycin without detectable changes in creatinine clearance.
Topics: Adult; Aged; Anti-Bacterial Agents; Creatinine; Female; Gentamicins; Half-Life; Humans; Kidney Failu | 1979 |
[Sisomicin dosage in renal failure].
Topics: Acute Kidney Injury; Gentamicins; Humans; Kidney Failure, Chronic; Kinetics; Sisomicin | 1979 |
Drug elimination by hemofiltration.
Topics: Ampicillin; Anti-Bacterial Agents; Clofibrate; Doxycycline; Filtration; Gentamicins; Humans; Kidney | 1977 |
Pharmacokinetics of netilmicin in the presence of normal or impaired renal function.
Topics: Adult; Aged; Creatinine; Gentamicins; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Middle A | 1978 |
Nephrotoxic antibiotics in patients with renal failures: guidelines for debilitated patients.
Topics: Aminoglycosides; Body Weight; Creatine; Emaciation; Gentamicins; Humans; Kidney; Kidney Failure, Chr | 1979 |
[Serratia marcescens infections in chronic hemodialysis patients].
Topics: Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Gentamicins; Germany, Ea | 1975 |
Gentamicin pharmacokinetics during hemodialysis in patients suffering from chronic renal failure.
Topics: Adult; Female; Gentamicins; Humans; Injections, Intravenous; Kidney Failure, Chronic; Kinetics; Male | 1977 |
[Nephrotoxicity of gentamicin. Conditions for the use of this antibiotic in the elderly and in the patient with renal insufficiency].
Topics: Acute Kidney Injury; Adult; Age Factors; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Fem | 1977 |
Inactivation of gentamicin by penicillins in patients with renal failure.
Topics: Carbenicillin; Gentamicins; Humans; Kidney Failure, Chronic; Kinetics; Penicillins; Ticarcillin; Tim | 1976 |
Carbenicillin inactivation of aminoglycosides in patients with severe renal failure.
Topics: Aged; Anti-Bacterial Agents; Carbenicillin; Drug Interactions; Drug Therapy, Combination; Female; Ge | 1976 |
Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies.
Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae I | 1976 |
[Determination of the optimal gentamicin dosage in limited kidney function].
Topics: Biological Availability; Gentamicins; Humans; Kidney Failure, Chronic; Microbial Sensitivity Tests | 1976 |
Practical pharmacokinetic techniques for drug consultation and evaluation. IV: Gentamicin blood level versus time profiles of various dosage regimens recommended for renal impairment.
Topics: Adult; Aged; Computers; Creatinine; Female; Gentamicins; Half-Life; Humans; Kidney Failure, Chronic; | 1975 |
[Antibiotic therapy and renal insufficiency. Pharmacokinetics of pivampicillin, cephaloridin and streptomycin in chronic uremic patients undergoing conservative or hemodialytic treatment].
Topics: Ampicillin; Binding Sites; Carbenicillin; Cephalexin; Cephaloridine; Chronic Disease; Gentamicins; H | 1975 |
Prophylactic antibiotics in the insertion of Tenckhoff catheters.
Topics: Adult; Aged; Catheters, Indwelling; Cefazolin; Female; Gentamicins; Humans; Kidney Failure, Chronic; | 1992 |
Beneficial effects of the urinary trypsin inhibitor urinastatin on renal insults induced by gentamicin and mercuric chloride (HgCl2) poisoning.
Topics: Animals; Dose-Response Relationship, Drug; Epithelium; Gentamicins; Glomerular Filtration Rate; Glyc | 1991 |
Isepamicin disposition in subjects with various degrees of renal function.
Topics: Adult; Aged; Female; Gentamicins; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Ma | 1991 |
Vestibular toxicity due to gentamicin in peritoneal dialysis patients.
Topics: Adult; Aged; Bacterial Infections; Catheters, Indwelling; Female; Gentamicins; Humans; Infusions, Pa | 1991 |
Gentamicin and vancomycin removal by continuous venovenous hemofiltration.
Topics: Bayes Theorem; Drug Administration Schedule; Endocarditis, Bacterial; Gentamicins; Hemofiltration; H | 1991 |
[Peritonitis in continuous ambulatory peritoneal dialysis. Microbiological and clinical evaluation].
Topics: Adult; Aged; Cephalothin; Drug Resistance, Microbial; Female; Gentamicins; Humans; Kidney Failure, C | 1990 |
Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
Topics: Carbamazepine; Cross Reactions; Digoxin; Gentamicins; Humans; Immunoassay; Kidney Failure, Chronic; | 1986 |
Chronic tubulointerstitial nephritis and renal insufficiency associated with long-term "subtherapeutic" gentamicin.
Topics: Animals; Autoradiography; Gentamicins; Glomerular Filtration Rate; Inulin; Kidney Failure, Chronic; | 1988 |
Renal cortical uptake kinetics of gentamicin in rats with impaired renal function.
Topics: Animals; Creatinine; Female; Gentamicins; Glomerular Filtration Rate; Kidney Cortex; Kidney Failure, | 1986 |
Time course of gentamicin serum concentration rebound following hemodialysis.
Topics: Aged; Creatinine; Gentamicins; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Renal D | 1987 |
Early monitoring of human renal transplantations by N-acetyl-beta-D-glucosaminidase isoenzyme activities in urines.
Topics: Acetylglucosaminidase; Gentamicins; Graft Rejection; Hexosaminidases; Humans; Isoenzymes; Kidney Fai | 1985 |
[Intracellular calcium and renal function].
Topics: Acute Kidney Injury; Animals; Biological Transport, Active; Calcium; Calcium Channel Blockers; Calmo | 1985 |
Carbenicillin-induced coagulopathy.
Topics: Adult; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Carbenicillin; Femal | 1974 |
[Deafness and gentallin].
Topics: Adult; Audiometry; Cochlea; Deafness; Ear, Inner; Female; Gentamicins; Humans; Kidney Failure, Chron | 1972 |
[Gentamicin and auricular toxicity].
Topics: Adult; Animals; Audiometry; Deafness; Ear Diseases; Ear, Inner; Female; Gentamicins; Guinea Pigs; Hi | 1969 |
[Antibiotics in renal insufficiency (author's transl)].
Topics: Acute Kidney Injury; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephaloridine; Cephalothin; C | 1974 |
Gentamicin pharmacokinetics during hemodialysis.
Topics: Adult; Blood Proteins; Creatinine; Female; Gentamicins; Glomerular Filtration Rate; Humans; In Vitro | 1974 |
Infections in renal failure.
Topics: Acute Kidney Injury; Ampicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalothin; | 1973 |
[Antibiotic therapy].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Colistin; Drug Therapy | 1973 |
[Nephrology in 1972].
Topics: Bone Resorption; Calcium; Dextrans; Female; Fluorescent Antibody Technique; Gentamicins; Glomerulone | 1972 |
Neomycin toxicity from porcine skin xenografts.
Topics: Aged; Animals; Burns; Chromatography, Paper; Deafness; Ear; Female; Gentamicins; Humans; Kidney; Kid | 1974 |
Gentamicin therapy in renal failure: a nomogram for dosage.
Topics: Adult; Aged; Bacillus subtilis; Bacterial Infections; Creatinine; Gentamicins; Half-Life; Humans; In | 1972 |
[Urologic surgery in urinary infections and renal failure].
Topics: Cephalothin; Colistin; Enterococcus faecalis; Escherichia coli Infections; Gentamicins; Humans; Kana | 1973 |
[Elimination kinetics of gentamicin in kidney insufficiency].
Topics: Adult; Aged; Creatinine; Female; Gentamicins; Humans; Kidney Failure, Chronic; Kinetics; Male; Metab | 1973 |
[Side-effects of gentamicin. Report of a case treated for an unusually long period].
Topics: Female; Gentamicins; Humans; Infant; Kidney Diseases; Kidney Failure, Chronic; Time Factors; Urinary | 1973 |
[Gentamicin and peritoneal dialysis].
Topics: Acute Kidney Injury; Gentamicins; Humans; Kidney Failure, Chronic; Peritoneal Dialysis | 1973 |
[Gentamicin and hemodialysis].
Topics: Acute Kidney Injury; Gentamicins; Humans; Kidney Failure, Chronic; Renal Dialysis | 1973 |
[Pharmacokinetics of gentamicin in adults and children of various ages].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Gentamicins; Humans; Infant; Kidney Failur | 1973 |
[The difficulties of drug management in renal insufficiency (author's transl)].
Topics: Acute Kidney Injury; Gentamicins; Humans; Kidney Failure, Chronic; Tetracycline | 1974 |
The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function.
Topics: Creatinine; Gentamicins; Humans; Kidney Failure, Chronic | 1974 |
Peritoneal clearance and removal of gentamicin.
Topics: Acute Kidney Injury; Aged; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kidney Failur | 1971 |
The use of gentamicin in peritoneal dialysis. II. Microbiologic and clinical results.
Topics: Acute Kidney Injury; Alcaligenes; Candidiasis; Carbenicillin; Cephalothin; Drug Synergism; Escherich | 1971 |
[Pharmacokinetics of gentamycin sulfate in the healthy and in patients with terminal renal failure].
Topics: Bacillus subtilis; Feces; Gentamicins; Half-Life; Humans; Kidney; Kidney Failure, Chronic; Male; Per | 1971 |
Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.
Topics: Bacillus cereus; Bacterial Infections; Culture Media; Gentamicins; Humans; Kanamycin; Kidney Failure | 1971 |
Relation between dose and levels of gentamicin in blood.
Topics: Acute Kidney Injury; Agar; Biological Assay; Clinical Laboratory Techniques; Creatinine; Gentamicins | 1971 |
[Recent developments in antibiotics].
Topics: Bacteria; Carbenicillin; Culture Techniques; Drug Antagonism; Drug Synergism; Gentamicins; Humans; K | 1972 |
Correlation of serum creatinine concentration and gentamicin half-life.
Topics: Creatinine; Gentamicins; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Staphylococcus | 1972 |
The use of gentamicin in peritoneal dialysis. I. Pharmacologic results.
Topics: Acute Kidney Injury; Drug Resistance, Microbial; Gentamicins; Half-Life; Humans; Injections, Intramu | 1971 |
[Review of observed gentamicin ototoxicity cases in Germany].
Topics: Adolescent; Adult; Aged; Diabetes Complications; Drug Synergism; Ethacrynic Acid; Gentamicins; Germa | 1971 |
[Antimicrobial chemotherapy in liver and kidney lesions].
Topics: Aminosalicylic Acids; Anti-Infective Agents; Creatinine; Gentamicins; Humans; Kidney Failure, Chroni | 1971 |
A case of gentamicin accentuated hearing loss.
Topics: Adult; Audiometry; Deafness; Gentamicins; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Str | 1968 |
Renal tissue levels of gentamicin and a dose schedule in renal impairment.
Topics: Animals; Dogs; Gentamicins; Humans; Kidney; Kidney Failure, Chronic | 1969 |